Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02876107
Brief Title: A Phase II Study of Using Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen (AC) for New Triple-Negative Inflammatory Breast Cancer (TN-IBC)

First Submitted : August 18, 2016
First Submitted that Met QC Criteria : August 18, 2016
First Posted : August 23, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 25, 2018
Last Update Posted : July 26, 2018